Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Phosphorylation Protects Oncogenic RAS from LZTR1-Mediated Degradation.
Journal: Blood cancer discovery
Published: January 23, 2026
Phosphorylation Protects Oncogenic RAS from LZTR1-Mediated Degradation.
Journal: bioRxiv : the preprint server for biology
Published: January 16, 2026
The anti-CD47 antibody magrolimab with obinutuzumab and venetoclax in relapsed or refractory indolent B-cell lymphomas.
Journal: British journal of haematology
Published: March 28, 2025
Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma.
Journal: The New England journal of medicine
Published: June 20, 2024
Phosphatidylserine phospholipase A1 enables GPR34-dependent immune cell accumulation in the peritoneal cavity.
Journal: The Journal of experimental medicine
Published: June 09, 2024
Gα13 restricts nutrient driven proliferation in mucosal germinal centers.
Journal: Nature immunology
Published: January 16, 2024
IRF4 requires ARID1A to establish plasma cell identity in multiple myeloma.
Journal: Cancer cell
Published: January 12, 2024
Molecular Determinants of Sensitivity to Polatuzumab Vedotin in Diffuse Large B-Cell Lymphoma.
Journal: Cancer discovery
Published: July 15, 2023
Antigen receptor signaling and cell death resistance controls intestinal humoral response zonation.
Journal: Immunity
Published: February 19, 2023
Targeting N-linked Glycosylation for the Therapy of Aggressive Lymphomas.
Journal: Cancer discovery
Published: December 12, 2022
Multi-omic profiling of follicular lymphoma reveals changes in tissue architecture and enhanced stromal remodeling in high-risk patients.
Journal: Cancer cell
Published: July 19, 2022
Last Updated: 09/26/2026